ITC partners with Amway to develop range of immunity boosting products

Launches fruit juices with clinically proven immunity boosters, which will be sold by Amway's micro-entrepreneurs for a while

ITC
Reports say demand for immunity-building products has gone up four times post-Covid-19.
Samreen Ahmad Bengaluru
2 min read Last Updated : May 28 2020 | 5:51 PM IST
With sales of immunity building products seeing an uptick in demand after the Covid-19 outbreak, FMCG giant ITC has partnered with direct selling company Amway India to launch a range of products in the segment, the first being a one-of-its-kind immunity offering in fruit beverages.

Priced at Rs 130, the new B Natural + range of fruit juices contain clinically proven immunity boosters and will be sold by Amway’s micro-entrepreneurs for a limited time period, before ITC starts using its pan-India distribution network. 

“At ITC, we are unique in the number of product formats that we have and each of these formats can actually be leveraged for a specific consumer benefit with the product and nutrition science that Amway has and our ability to do product development on those,” said Hemant Malik, Divisional Chief Executive − Foods Division, ITC. He said this is the first glimpse of an immunity product and several others will be launched in the coming months. 

Reports say demand for immunity-building products has gone up four times post-Covid-19. While FMCG companies such as Dabur have posted overall losses during the fourth quarter, immunity products such as chyawanprash and honey have seen over an 80 per cent surge in demand. 

Experts say even juices are benefitting from more in-home consumption. “Apart from regular benefits of health and Ayurveda focus, juices could get the much-needed fillip to growth. We note that juices performance could improve benefiting from greater in-home consumption versus other beverage categories like carbonated soft drinks,” said ICICI Securities in a note.

According to Malik, ITC and Amway were already in talks for a strategic collaboration long before the signs of Covid19 emerged in India and the outbreak fast-tracked the partnership.

Amway India CEO Anshu Budhraja said it is piloting and testing ground and also deploying resources and science-based research to strengthen the partnership further. 

“As we inch towards the food segment, we are confident of creating immense value for people through this partnership and further solidify our leadership in the health and immunity domain,” said Budhraja.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusLockdownEntrepreneurshipITC

Next Story